SANTINI, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 1.796
EU - Europa 1.088
AS - Asia 268
OC - Oceania 67
SA - Sud America 35
AF - Africa 12
AN - Antartide 1
Totale 3.267
Nazione #
US - Stati Uniti d'America 1.696
GB - Regno Unito 699
IT - Italia 138
IN - India 112
CA - Canada 94
DE - Germania 78
AU - Australia 65
TR - Turchia 33
FR - Francia 25
JP - Giappone 23
BR - Brasile 19
CN - Cina 19
FI - Finlandia 19
BE - Belgio 16
NL - Olanda 16
HK - Hong Kong 12
CH - Svizzera 10
ES - Italia 10
ID - Indonesia 9
SA - Arabia Saudita 9
RU - Federazione Russa 8
IL - Israele 7
SG - Singapore 7
HU - Ungheria 6
PL - Polonia 6
SK - Slovacchia (Repubblica Slovacca) 6
AR - Argentina 5
AT - Austria 5
PE - Perù 5
SI - Slovenia 5
TW - Taiwan 5
KR - Corea 4
LU - Lussemburgo 4
RO - Romania 4
SE - Svezia 4
ZA - Sudafrica 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
CL - Cile 3
EG - Egitto 3
GR - Grecia 3
KW - Kuwait 3
MX - Messico 3
NG - Nigeria 3
TH - Thailandia 3
AM - Armenia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BY - Bielorussia 2
CY - Cipro 2
EE - Estonia 2
IE - Irlanda 2
IQ - Iraq 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
PT - Portogallo 2
RS - Serbia 2
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
FK - Isole Falkland (Malvinas) 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HR - Croazia 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
LT - Lituania 1
MD - Moldavia 1
MS - Montserrat 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
PH - Filippine 1
SL - Sierra Leone 1
TN - Tunisia 1
UA - Ucraina 1
YE - Yemen 1
Totale 3.267
Città #
Ashburn 960
London 654
San Francisco 136
Boardman 104
Pune 98
Seattle 95
Toronto 85
Washington 69
Council Bluffs 68
Rome 39
Melbourne 32
Helsinki 19
Los Angeles 19
Canberra 17
Tokyo 17
Sydney 16
West Jordan 16
New York 13
Amsterdam 12
Hanover 12
Hasselt 12
St Louis 11
Haikou 9
Riyadh 9
Secaucus 9
São Paulo 9
Milan 8
Paris 8
Markham 7
Oklahoma City 7
Redmond 7
Central 6
Frankfurt am Main 6
Santa Clara 6
Singapore 6
Warsaw 6
Bratislava 5
Lima 5
Ljubljana 5
New Taipei 5
San Pietro in Lama 5
Vienna 5
Budapest 4
Haifa 4
Lincoln 4
Luxembourg 4
Reston 4
San Ferdinando Di Puglia 4
Andover 3
Athens 3
Barcelona 3
Brussels 3
Centurion 3
Durham 3
Ferrara di Monte Baldo 3
Hyderabad 3
Kuwait City 3
Monza 3
Ningbo 3
Padova 3
Palermo 3
Sarajevo 3
Shanghai 3
Tirana 3
Abuja 2
Alba 2
Anyang 2
Atlanta 2
Bangkok 2
Bengaluru 2
Berlin 2
Borås 2
Cairo 2
Caltanissetta 2
Caluire-et-Cuire 2
Cardiff 2
Cassago Brianza 2
Charleston 2
Charlotte 2
Chicago 2
Dublin 2
Gimpo-si 2
Hong Kong 2
Islamabad 2
Keputih 2
Kragujevac 2
Lancaster 2
Lombard 2
Madrid 2
Mexico City 2
Minsk 2
Nagoya 2
Naples 2
Nicosia 2
Redwood City 2
Riga 2
San Nicola la Strada 2
Seoul 2
Sofia 2
Surabaya 2
Totale 2.781
Nome #
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference? 26
Skeletal alkaline phosphatase as a serum marker of bone metastases in the follow-up of patients with breast cancer 25
Ineffective target therapy in non-small cell lung cancer harboring BRAF G466R mutation: a case report and biological rationale 16
Uncommon EGFR mutations in non-small-cell lung cancer 15
New perspectives: role of Sunitinib in breast cancer 15
Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis? 15
Use of Cardioprotective Dexrazoxane Is Associated with Increased Myelotoxicity in Anthracycline-Treated Soft-Tissue Sarcoma Patients 15
Human equilibrative nucleoside transporter 1 as a predictor of efficacy to gemcitabine in advanced leiomyosarcoma and angiosarcoma 14
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer 13
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes 13
Improving quality of life in patients with advanced cancer: Targeting metastatic bone pain 13
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 13
An increase of CA 19.9 as the first clinical sign of ileocecal valve metastasis from breast cancer 12
Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer Patients 11
Oxaliplatin may induce cytokine-release syndrome in colorectal cancer patients 11
Surgical complications after resection of adrenal carcinoma 11
Colorectal carcinomas and PTEN/MMAC1 gene mutations 11
Classic Kaposi Sarcoma: to treat or not to treat? 11
Clinical impact of first-line bevacizumab plus chemotherapy in metastatic colorectal cancer of mucinous histology: a multicenter, retrospective analysis on 685 patients 11
A rare case of primary lymphoma of the breast and metachronous breast primitive lobular carcinoma: case report 11
Integrin alpha-5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions 11
Natural history of skeletal disease in primary biliary cancers. National survey on behalf of GICO group (Gruppo Italiano Colangiocarcinoma – Onlus) 11
Erratum: Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients (British Journal of Cancer (2005) 92 (2225-2232) DOI: 10.1038/sj.bjc.6602632) 11
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions 11
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 10
La dimensione tutoriale della formazione clinica dello studente [The tutorial dimension of clinical training of students]. 10
The role of Aurora-A inhibitors in cancer therapy 10
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 10
New developments of aminobisphosphonates: the double face of Janus 10
Complications of therapy in cancer patients: Case 3. Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient 10
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 10
Anestesia e malattie non comuni 10
The role of S-adenosyl methionine in preventing FOLFOX-induced liver toxicity: a retrospective analysis in patients affected by resected colorectal cancer treated with adjuvant FOLFOX regimen 10
Role of glyoxalase-1 in trabectedin-resistant myxoid liposarcoma 10
Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21) 10
Dicer and Drosha Expression and Response to Bevacizumab-Based Therapy in Advanced Colorectal Cancer Patients 10
Bone metastases in biliary cancers: A multicenter retrospective survey 9
Cabozantinib and apixaban: an hitherto unreported interaction 9
Severe liver dysfunction after raltitrexed administration in an HCV-positive colorectal cancer patient 9
The dark side of the moon: The PI3K/PTEN/AKT pathway in colorectal carcinoma 9
Investigational therapies targeting signal transducer and activator of transcription 3 for the treatment of cancer. 9
A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation 9
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 9
Genetic modulation of the Let-7 microRNA binding to KRAS 3 '-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan 9
hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma 9
COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables 9
Neutrophil-to-lymphocyte ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and outcomes with nivolumab in pretreated Non-Small Cell Lung Cancer (NSCLC): a large retrospective multicenter study 9
Esperienza della Libera Università Campus Bio-Medico sui sistemi Port-A-Cath venosi in oncologia 9
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 9
Biological effects of cabozantinib on bone microenvironment 9
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 9
S-Adenosylmethionine Supplementation May Reduce Cancer-Related Fatigue: A Prospective Evaluation Using the FACIT-F Questionnaire in Colon Cancer Patients Undergoing Oxaliplatin-Based Chemotherapy Regimens 9
Cabozantinib affects osteosarcoma growth through a direct effect on tumor cells and modifications in bone microenvironment 8
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance? (vol 23, pg 2313, 2012) 8
Interventional radiologist's perspective on the management of bone metastatic disease 8
Coronavirus disease 2019 or lung cancer: what should we treat? 8
Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review 8
Premetastatic niche: ready for new therapeutic interventions? 8
Role of KRAS let-7 LCS6 SNP in metastatic colorectal cancer patients 8
Bisphosphonate effects in cancer and inflammatory diseases - In vitro and in vivo modulation of cytokine activities 8
Letter to the editor 8
Recurrent thrombophlebitis in a colon cancer patient with C677T heterozygous genotype for MTHFR treated with 5-fluorouracil-based adjuvant chemotherapy 8
Zoledronic acid in the management of metastatic bone disease 8
Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV 8
Update on capecitabine alone and in combination regimens in colorectal cancer patients 8
Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility? 8
Management of metastatic renal cell carcinoma patients with poor-risk features: current status and future perspectives. 8
Testosterone levels and androgen receptor copy number variations in castration-resistant prostate cancer treated with abiraterone or enzalutamide 8
Randomised phase II trial of CAPTEM or FOLFIRI as SEcond-line therapy in NEuroendocrine CArcinomas and exploratory analysis of predictive role of PET/CT imaging and biological markers (SENECA trial): a study protocol 8
Molecular predictive factors of response to anti-EGFR antibodies in colorectal cancer patients 8
Carcinoma of the Ampulla of Vater morphological and immunophenotypical classification predicts overall survival 8
Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma 8
Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer 8
Immunomodulating role of bisphosphonates on human gamma delta T cells: an intriguing and promising aspect of their antitumour activity 8
A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: An open-label, non randomized, pilot study 8
Safety analysis, association with response and previous treatments of everolimus and exemestane in 181 metastatic breast cancer patients: A multicenter Italian experience 8
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview 8
Bone Health in Cancer Patients 8
Zoledronic acid for the treatment of appendicular osteosarcoma in a dog 8
Corrigendum: Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter? (vol 13, pg 2791, 2017) 8
Updated follow-up of patients treated with bortezomib for relapsed multiple myeloma 8
Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions 8
Percutaneous management of bone metastases: state of the art, interventional strategies and joint position statement of the Italian College of MSK Radiology (ICoMSKR) and the Italian College of Interventional Radiology (ICIR) 8
Facing SARS-CoV-2 outbreak in immunotherapy era 8
Feasibility of Eribulin Mesylate in older patients with locally advanced or metastatic breast cancer: A post-hoc analysis of the ESEMPiO study 8
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 8
Cox-2 Expression in Different Histotypes of Ampullary Carcinoma 8
Drug-induced hepatotoxicity in cancer patients - implication for treatment 8
'Old' and 'new' drugs for the treatment of cancer pain 8
M1-polarized macrophages as predictor of poor response to trabectedin treatment in myxoid liposarcoma 8
Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic Implications 8
Interleukin 1ss-511T gene (IL1ss) polymorphism is correlated with gastric cancer in the Caucasian population: Results from a meta-analysis 7
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance? 7
Pancreatic intraductal papillary mucinous neoplasms: a paradigmatic case. A case report and review of the literature 7
Pamidronate induces modifications of circulating angiogenetic factors in cancer patients 7
Idiosyncratic reaction after oxaliplatin infusion 7
Correspondence Re: E. Corey et al., Zoledronic Acid Exhibits Inhibitory Effects on Osteoblastic and Osteolytic Metastases of Prostate Cancer 7
Cutting the Limits of Aminobisphosphonates: New Strategies for the Potentiation of their Anti-Tumour Effects 7
A key opinion leader interview with Prof D Santini: insight into cancer research. 7
Lack of response of cetuximab plus oxaliplatin in advanced colorectal cancer patients resistant to both oxaliplatin and cetuximab plus irinotecan 7
Totale 965
Categoria #
all - tutte 125.041
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.041


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.021 0 5 5 8 73 10 15 4 42 20 24 815
2022/2023206 18 7 3 13 18 7 18 20 9 3 81 9
2023/20242.153 52 283 98 172 242 1.054 18 154 25 55 0 0
Totale 3.380